New targeted therapies for relapsed pediatric acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New targeted therapies for relapsed pediatric acute lymphoblastic leukemia

Published:2017-07-05 Issue:8 Volume:17 Page:725-736
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Pierro Joanna¹,Hogan Laura E.²,Bhatla Teena¹,Carroll William L.¹

Affiliation:

1. Division of Pediatric Hematology Oncology, Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY, USA

2. Division of Pediatric Hematology/Oncology, Department of Pediatrics, Stony Brook Children’s, Stony Brook, NY, USA

Funder

Leukemia and Lymphoma Society

National Institutes of Health

Three Strohm Sister’s Foundation

Perlmutter Cancer Center

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2017.1347507

Reference99 articles.

1. Cancer Incidence Rates and Trends Among Children and Adolescents in the United States, 2001–2009

2. Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group

3. Where do we stand in the treatment of relapsed acute lymphoblastic leukemia?

4. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

5. Clinical and Laboratory Biology of Childhood Acute Lymphoblastic Leukemia

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL);Current Treatment Options in Oncology;2024-08-05

2. Andrographolide acts with dexamethasone to inhibit the growth of acute lymphoblastic leukemia CEM‑C1 cells via the regulation of the autophagy‑dependent PI3K/AKT/mTOR signaling pathway;Biomedical Reports;2024-01-19

3. Pediatric Acute Leukemias;Tata Memorial Centre Textbook of Oncology;2024

4. Nüks Eden Akut Lenfoblastik Lösemili Düşük ve Orta Gelirli Çocukların Sonuçları: Tek Merkez Deneyimi;Journal of Contemporary Medicine;2023-09-30

5. ADAR1 polymorphisms contribute to increased susceptibility in pediatric acute lymphoblastic leukemia;Annals of Hematology;2023-05-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3